when will semaglutide be cheaper #VantageOnFirstpost: Goes Generic in India: Drugs could as cheap as $14 , India has just entered its Ozempic era. With the patent expiry of Semaglutide, the key ingredient behind Popular — and expensive —

The incidence of gastrointestinal adverse events was 72.5% with CagriSema versus 34.4% with placebo, predominantly transient and mild to moderate in severity

Zepbound and other GLP-1s can cause gastroparesis

Injection site reactions were also relatively common (exenatide 39%, placebo 22%)

The labels mention cardiovascular risk reduction based on the SELECT trial data but do not address thrombotic risk

Body weight influences needslarger individuals generally require more fluid, though personalized targets should be developed with healthcare providers

The potential benefits of Retatrutide are extensive and span a wide range of medical conditions and health concerns